Lysophosphatidic acid (LPA) is a naturally occurring phospholipid with growth-factor-like activities [van Corven,Groenink,Jalink,Eichholtz & Moolenaar (1989) Cell 45,45-54]. We have examined various structural analogues of LPA for their ability to stimulate DNA synthesis in quiescent fibroblasts. When the acyl-chain length is varied,the rank order of mitogenic potency is: 1-oleoyl LPA congruent to 1-palmitoyl LPA greater than 1-myristoyl LPA greater than 1-lauroyl LPA greater than 1-decanoyl LPA; the last compound shows almost no activity over the concentration range tested (1-100 microM). An ether-linked LPA (1-O-hexadecylglycerol 3-phosphate) has much decreased mitogenic activity as compared with the ester-linked analogue at concentrations less than 25 microM,and becomes cytotoxic at higher concentrations. Hexadecylphosphate,which lacks a glycerol backbone,has negligible activity. On a molar basis,diacyl phosphatidic acid (PA) is about equally potent as the corresponding LPA analogue,showing similar acyl-chain-length dependence; the data argue against the possibility that the mitogenic action of PA is due to contaminating traces of LPA. Although the short-chain analogues of LPA and PA fail to antagonize the action of long-chain (L)PAs,the polyanionic drug suramin inhibits LPA- and PA-induced,DNA synthesis in a reversible and dose-dependent manner,at concentrations [IC50 (concn. giving 50% inhibition) approximately 70 microM] that do not affect epidermal-growth-factor-induced DNA synthesis. Suramin appears to act in the early G0/G1 phase of the cell cycle,blocking immediate responses to LPA such as phosphoinositide hydrolysis. We conclude that both LPA and PA can function as growth-promoting phospholipids,with the fatty acid chain length being a major determinant of mitogenic potency.
View Publication